Sandy Matalonis
Consultant / Advisor presso Ben Franklin Technology Partners /Ventures/
Profilo
Sandy Matalonis is currently an Advisor at Ben Franklin Technology Partners since 2008.
She previously worked as a Director at Incyte Corp.
and the University of Pennsylvania from 1991 to 1997.
From 2008 to 2017, she was an Executive Director at Iroko Pharmaceuticals LLC.
In 2018 to 2019, she worked as a Senior Director at Tmunity Therapeutics, Inc. Ms. Matalonis received her undergraduate degree from The Pennsylvania State University in 1991 and her MBA from Alfred Lerner College of Business & Economics in 2001.
Posizioni attive di Sandy Matalonis
| Società | Posizione | Inizio |
|---|---|---|
Ben Franklin Technology Partners /Ventures/
 Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Technology Partners /Ventures/ (Ben Franklin Tech Partners) is a venture Capital firm founded in 1982. The firm is headquartered in Philadelphia, Pennsylvania. | Consultant / Advisor | 01/01/2008 |
Precedenti posizioni note di Sandy Matalonis
| Società | Posizione | Fine |
|---|---|---|
Tmunity Therapeutics, Inc.
 Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | Private Equity Investor | 01/08/2019 |
Iroko Pharmaceuticals LLC
 Iroko Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Iroko Pharmaceuticals LLC develops and distributes pharmaceutical products. It provides approved US products, marketed global, medical information and product patents. The company was founded in 2007 and is headquartered in Philadelphia, PA. | Private Equity Investor | 01/05/2017 |
| University of Pennsylvania | Director/Board Member | 01/01/1997 |
| INCYTE CORPORATION | Director/Board Member | - |
Formazione di Sandy Matalonis
| The Pennsylvania State University | Undergraduate Degree |
| Alfred Lerner College of Business & Economics | Masters Business Admin |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Società quotate in Borsa | 1 |
|---|---|
| INCYTE CORPORATION | Health Technology |
| Aziende private | 3 |
|---|---|
Ben Franklin Technology Partners /Ventures/
Ben Franklin Technology Partners /Ventures/ Investment ManagersFinance Ben Franklin Technology Partners /Ventures/ (Ben Franklin Tech Partners) is a venture Capital firm founded in 1982. The firm is headquartered in Philadelphia, Pennsylvania. | Finance |
Iroko Pharmaceuticals LLC
Iroko Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Iroko Pharmaceuticals LLC develops and distributes pharmaceutical products. It provides approved US products, marketed global, medical information and product patents. The company was founded in 2007 and is headquartered in Philadelphia, PA. | Health Technology |
Tmunity Therapeutics, Inc.
Tmunity Therapeutics, Inc. Miscellaneous Commercial ServicesCommercial Services Tmunity Therapeutics, Inc. develops novel products that free the immunological potential of T cells to treat disease indications. It develops novel T Cell Receptor (TCR) engineered T cells, regulatory T cells (Treg), and universal engineered T cell platforms. The company was founded by Carl H. June, Anne Chew, Bruce Levine, Yangbing Zhao, James L. Riley and Bruce Blazar and is headquartered in Philadelphia, PA. | Commercial Services |
- Borsa valori
- Insiders
- Sandy Matalonis
